Literature DB >> 33544807

Chameleonic appearance of caseous calcification of the mitral valve - still a problem for its appropriate management.

Caius Glad Streian1, Ana Lascu, Raluca Şoşdean, Ciprian Nicuşor Dima, Florin Grosu, Adrian Costache, Andrei Gheorghe Marius Motoc.   

Abstract

According to the research literature, the caseous calcification of the mitral annulus (CCMA) is a rare variant of the mitral annulus calcification (MAC) entity, described mostly in elderly women. The aim of this study was to present the case of a 53-year-old female patient with caseous calcification of the mitral valve annulus and posterior cusp, which was diagnosed as papillary fibroelastoma. An echo-dense and quasi-homogeneous tumoral mass, measuring 1.6∕1.4 cm, at the level of the posterior mitral ring was detected by echocardiographic examination, as well as by cardiac magnetic resonance imaging (MRI). Histopathological analysis revealed fibrous connective tissue with myxoid areas, hyaline degeneration with unstructured necrosis and dystrophic calcifications, which was consisting with the operative findings of a "toothpaste tumor", or caseous calcification of the mitral valve. Differential diagnosis with other cardiac tumors, abscesses, thrombi or fibroelastomas is emphasized.

Entities:  

Year:  2020        PMID: 33544807      PMCID: PMC7864315          DOI: 10.47162/RJME.61.2.25

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


⧉ Introduction

There are several types of echo-dense masses that may be encountered on the native mitral valve ring and/or cusps. The most commonly described are myocardial abscesses, vegetations in infective endocarditis, thrombi and tumoral masses, which may include hemangioma of the mitral valve, intramural myxoma, leiomyosarcoma and/or fibroelastoma [1,2,3,4]. An estimated prevalence of approximately 0.6% of all cases of caseous mitral annulus calcification (MAC) can be sometimes mobile or produce mobile projections, which can embolize and be a source of stroke [5]. The caseous calcification of the mitral valve annulus is considered to be a rare entity representing caseous degeneration of the inner material in MAC and resembling as an echo-dense tumoral mass that typically affects the posterior annulus [6,7]. The cavity contents are composed of a calcium mixture, fatty acids, and cholesterol, with a “toothpaste-like” texture and it may present as an intracardiac mass or cavity [8]. It is usually benign but sometimes it may severely alter the mitral valve flow. It is important to distinguish between these masses in a correct manner using the available imaging techniques, as the correct diagnosis has important implications for the appropriate treatment [9]. Aim We present hereby a case of caseous calcification of the mitral valve annulus and posterior cusp, which was diagnosed as papillary fibroelastoma, known to induce embolization [10].

⧉ Case presentation

At the Department of Cardiology, Institute of Cardiovascular Diseases, affiliated to the Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania, a 53-year-old female patient was evaluated for recently diagnosed grade II arterial hypertension. She lacked any other known cardiac and/or extracardiac conditions. Her electrocardiography (ECG) and lab tests were normal. The echocardiographic examination showed normal sized heart cavities, with a normal left ventricular ejection fraction (60% by Simpson biplane method). An unexpected echo-dense and quasi-homogenous tumoral mass, measuring 1.6/1.4 cm, was detected at the level of the posterior mitral ring including the P2 segment of the posterior mitral leaflet, without any shadowing artifacts. The mass was round-shaped when examined in parasternal long axis and apical views (Figure 1A) and slightly oval shaped in parasternal short axis view, including most of the posterior mitral annulus and extending to the apical part of the P2 segment and apparently to the adjacent myocardium (Figure 1B). This resulted in a light mitral regurgitation. Infective endocarditis and mitral annulus abscess were excluded based on the patient’s clinical status and medical history.
Figure 1

Echocardiographic study: (A) Apical four-chamber view – echo-dense tumor mass at the level of the posterior mitral ring; (B) Parasternal short axis view

Echocardiographic study: (A) Apical four-chamber view – echo-dense tumor mass at the level of the posterior mitral ring; (B) Parasternal short axis view In order to better describe and distinguish the mass, a cardiac magnetic resonance imaging (MRI) was performed, which described a 138 mm3, well-defined, homogeneous tumor of the posterior mitral valve annulus and leaflet (mostly P2, extending to the medium–apical part) (Figure 2A), slightly hyperintense on T1-weighted sequences (Figure 2B) and slightly hypointense on T2-weighted sequences, with isointense signal during delayed postcontrast sequences/without late gadolinium enhancement/with slight peripheral late gadolinium enhancement. This aspect excluded any highly vascular tumor like myxoma, hemangioma and leiomyosarcoma. The mass was interpreted as a possible papillary fibroelastoma, keeping in mind also a possible diagnosis of caseous necrosis of the mitral valve annulus. The patient was referred to the Department of Cardiovascular Surgery, Institute of Cardiovascular Diseases, affiliated to the Victor Babeş University of Medicine and Pharmacy, Timişoara, for surgical management. The intra-operative appearance was of a round, homogenous mass with a firm consistency (Figure 3). A white fibrocaseous tissue was eliminated while cutting the tumor, this macroscopic aspect suggesting a so-called “toothpaste tumor”, or caseous calcification of the mitral valve (Figure 4). The mitral valve was replaced with a Sorin CarboMedics “Standard” 27 mm mechanical valve, with a good peri-operatory outcome, without any complications.
Figure 2

MRI study: (A) Cine sequence, telediastolic four-chamber view – the tumor can be seen very well at the level of the mitral valve; (B) T1 sequence, mitral valve short axis view. MRI: Magnetic resonance imaging

Figure 3

Intraoperative appearance of the posterior mitral valve with a roundish irregular homogeneous mass with a firm consistency

Figure 4

The macroscopic aspect suggesting a so-called “toothpaste tumor”, or caseous calcification (right), compared to the rest of the posterior mitral valve (left)

MRI study: (A) Cine sequence, telediastolic four-chamber view – the tumor can be seen very well at the level of the mitral valve; (B) T1 sequence, mitral valve short axis view. MRI: Magnetic resonance imaging Intraoperative appearance of the posterior mitral valve with a roundish irregular homogeneous mass with a firm consistency The macroscopic aspect suggesting a so-called “toothpaste tumor”, or caseous calcification (right), compared to the rest of the posterior mitral valve (left) Tumor fragments were sent to the Laboratory of Pathological Anatomy for histopathological and immunohistochemical (IHC) study. After fixation in 10% neutral buffered formalin, paraffin embedding and microtome sectioning, tumor fragments were stained with Hematoxylin–Eosin (HE) and Goldner–Szekely (GS) trichrome. The microscopic study showed the presence of fibrous connective tissue with myxoid areas (Figures 5 and 6), hyaline degeneration with unstructured necrosis, dystrophic calcifications, and diffuse chronic inflammatory infiltrate (Figures 7 and 8). Multinucleated macrophages were also detected, most probably due to an endogenous foreign body reaction (dystrophic calcifications). Some necrotic areas were surrounded by epithelioid histiocytes and/or by foamy macrophages.
Figure 5

Fibrosis and fibro-hyaline alteration of the mitral valve (GS trichrome staining, ×100).

Figure 6

Fibrous connective tissue with myxoid areas of the mitral valve (GS trichrome staining, ×100).

Figure 7

Dystrophic calcification, fibrinoid necrosis (chronic ulceration) and chronic inflammatory infiltrate of the mitral valve (HE staining, ×40).

Figure 8

Mitral valve with areas of dystrophic calcifications and abundant inflammatory infiltrate (HE staining, ×100).

Fibrosis and fibro-hyaline alteration of the mitral valve (GS trichrome staining, ×100). Fibrous connective tissue with myxoid areas of the mitral valve (GS trichrome staining, ×100). Dystrophic calcification, fibrinoid necrosis (chronic ulceration) and chronic inflammatory infiltrate of the mitral valve (HE staining, ×40). Mitral valve with areas of dystrophic calcifications and abundant inflammatory infiltrate (HE staining, ×100). For the IHC study, we used the following antibodies: anti-cluster of differentiation (CD) 3 (monoclonal mouse anti-human CD3, clone F7.2.38, 1/25 dilution, Dako), anti-CD20 (monoclonal mouse anti-human CD20cy, clone L26, 1/50 dilution, Dako), anti-CD68 (monoclonal mouse anti-human CD68, clone KP1, 1/100 dilution, Dako), anti-tryptase (monoclonal mouse anti-human mast cell tryptase, clone AA1, 1/500 dilution, Dako), anti-CD34 (monoclonal mouse anti-human CD34 class II, clone QBEnd-10, 1/50 dilution, Dako) and anti-alpha-smooth muscle actin (α-SMA) (monoclonal mouse anti-human SMA, clone 1A4, 1/100 dilution, Dako). IHC examinations showed that the tumor consisted of connective tissue with inhomogeneous structure, areas of calcification of various sizes and a diffuse inflammatory infiltrate. Areas where inflammatory infiltrate was abundant were also frequently identified. The inflammatory infiltrate was mainly composed of T-lymphocytes and macrophages, B-lymphocytes and mast cells being less identified (Figures 9,10,11,12). In some areas, numerous myofibroblasts have been identified, cells that are responsible for the synthesis of collagen fibers (Figure 13).
Figure 9

Tumor area with an abundant inflammatory infiltrate consisting mainly of T-lymphocytes (Immuno-staining with anti-CD3 antibody, ×200). CD3: Cluster of differentiation 3

Figure 10

Mitral valve area infiltrated with numerous macrophages (Immunostaining with anti-CD68 antibody, ×200). CD68: Cluster of differentiation 68

Figure 11

Mitral valve area with an abundant inflammatory infiltrate, but with a small number of B-lymphocytes (Immunostaining with anti-CD20 antibody, ×200). CD20: Cluster of differentiation 20

Figure 12

Image of tumor tissue with few mast cells present in the inflammatory infiltrate (Immunostaining with anti-tryptase antibody, ×200)

Figure 13

Mitral valve area rich in myofibroblasts (Immunostaining with anti-α-SMA antibody, ×200). α-SMA: Alpha-smooth muscle actin

Tumor vascularization was generally reduced, the blood vessels being few, except for the areas where the inflammatory infiltrate was abundant, areas where we found that the number of blood vessels was increased (Figure 14).
Figure 14

Moderate inflammatory infiltrate, with numerous angiogenesis capillaries in an area of the mitral valve (Immunostaining with anti-CD34 antibody, ×200). CD34: Cluster of differentiation 34

Tumor area with an abundant inflammatory infiltrate consisting mainly of T-lymphocytes (Immuno-staining with anti-CD3 antibody, ×200). CD3: Cluster of differentiation 3 Mitral valve area infiltrated with numerous macrophages (Immunostaining with anti-CD68 antibody, ×200). CD68: Cluster of differentiation 68 Mitral valve area with an abundant inflammatory infiltrate, but with a small number of B-lymphocytes (Immunostaining with anti-CD20 antibody, ×200). CD20: Cluster of differentiation 20 Image of tumor tissue with few mast cells present in the inflammatory infiltrate (Immunostaining with anti-tryptase antibody, ×200) Mitral valve area rich in myofibroblasts (Immunostaining with anti-α-SMA antibody, ×200). α-SMA: Alpha-smooth muscle actin Moderate inflammatory infiltrate, with numerous angiogenesis capillaries in an area of the mitral valve (Immunostaining with anti-CD34 antibody, ×200). CD34: Cluster of differentiation 34

⧉ Discussions

Echocardiographic images of caseous calcification are often heterogenous due to calcium and lipid deposits. The masses show hyperechogenic and hypoechogenic areas. However, the caseous calcification appearance can imitate that of abscess, tumors, and cysts. And surgical treatment may not be needed when there is no obstruction. This entity is diagnosed on cardiac MRI, multi-modality imaging, especially non-contrast computed tomography (CT), and allows for the confident and prospective diagnosis [11,12]. Microscopic examination in caseous calcification of the mitral annulus (CCMA) shows an amorphous acellular eosinophilic material with an inflammatory reaction based mostly on macrophages and lymphocytes surrounded and impregnated by necrotic and calcified tissue [1, 5], which is concordant with our findings. The timing of diagnosis and various amounts of calcified tissue, necrotic tissue, and inflammatory reaction, which may also vary in time, may be possible factors to induce the different imagistic aspect that made the diagnosis unclear. Cases that spontaneously resolved have already been published in the literature, demonstrating that this is a dynamic process [13]. CCMA is a rare variant of MAC entity, described mostly in elderly women. The mean age is 69 years old, with a history of hypertension, chronic kidney disease, especially with dialysis, calcium metabolism abnormalities, hypercholesterolemia, associated with a high calcium score, coronary artery disease (CAD) and aortic valve disease [14,15]. In ambulatory patients with CAD, mitral annular calcification was associated with inducible ischemia and subsequent cardiovascular events. MAC may indicate a high atherosclerotic burden and identifies patients at increased risk for adverse cardiovascular outcomes [16]. Given this profile, our 53-year-old patient, with a recently diagnosed hypertension is atypical, being the youngest reported with this disease, except for the renal failure patients. The exact mechanism of liquefaction necrosis is still unclear, but macrophages and an altered calcium metabolism seem to have a role [17]. Usually, this is an incidental finding. The echocardiographic aspect is of a large round or semilunar, inhomogeneous, echo-dense mass with central echolucency areas, without shadowing artifact [18]. Mid-basal involvement of the posterior mitral leaflet, besides the mitral annulus, was described with MAC but CCMA, with its tumoral aspect, is found in the posterior periannular area, rarely extending to the entire annulus, normally without mitral leaflet involvement [19]. Cases that involve the posterior and/or the anterior mitral valve leaflet are extremely rare [19,20]. In hemodialysis patients, MAC is common and often extensive. In this case, calcium may be unevenly distributed among the annular segments. When present, the annular calcification reduces the leaflet angle opening and can produce valvular dysfunction [21]. In our case, the tumor-like mass involved also P2 segment of the posterior mitral leaflet, and the central echolucent areas were not evident. Usually, tumors lack this area of echolucency, except for the ones with necrotic areas [22]. Therefore, the diagnosis was not strikingly clear by using only echocardiography. Whereas echocardiography was used to initially detect this mass and to assess its functional significance, the use of cardiac MRI was used to exclude other potential etiologies and to confirm the calcium presence. The conventional CT imaging further confirmed the calcified nature of the mass and most optimally demonstrated the transformation into caseous necrosis [23]. CT aspect is of a well-defined hyperdense mass, with peripheral calcification without contrast enhancement, but this investigation was not performed in our patient. MRI on the other hand is considered to be the method of choice in unclear cases. Here it is described as a well-defined mass, either hypointense in both T1- and T2-weighted sequences [24,25], or hyperintense in the central area with a hypointense rim in T1, discrete from the surrounding myocardium and as a mass with a hypodense central area with a high intensity ring in T2-weighted sequences [1]. In postcontrast studies, there is no contrast enhancement on first-pass sequences, but peripheral late gadolinium enhancement may be detected [2]. MRI aspect described in our case was not that obvious, the mass lacking any evident rims. The diagnosis of CCMA was still an option but valvular papillary fibroelastoma could not be excluded. This usually appears as uniform intermediate signal intensity mass similar to myocardium in T1- and T2-weighted sequences, normally lacking contrast enhancement, although cases with uniform late enhancement were reported [26]. Also, leaflet involvement, the age of the patient and the recently diagnosed hypertension as the only risk factor did not favor caseous calcification. Although cases of CCMA embolization were reported in the literature [1, 4, 10, 27], due to surface thrombus formation, calcified material embolization and/or fistulization with necrotic material embolization, it is considered to be a benign entity and conservative treatment is usually recommended [28,29]. Surgical management is recommended in cases with significantly impaired valve function (severe stenosis and/or regurgitation), in cases with evidence of systemic embolism and in doubtful cases, when the diagnosis is not clear [1, 18]. Severe MAC makes valve surgery more difficult. The surgery risks and benefits must be carefully assessed in patients with significant MAC, as increased surgical mortality has been observed in these patients [30]. For the patients with documented calcified emboli or repeated thromboembolism despite anticoagulation, the valve replacement may be considered [31]. The association between MAC and incident atrial fibrillation may be partially explained by the left atrial enlargement [32]. The mitral annular calcification is an increasing problem in elderly people, causing both mitral stenosis and regurgitation, which are difficult to treat. There is a little experience with the use of transcatheter valves by either a catheter-based approach or as a hybrid technique [33]. The eighth edition of the American College of Chest Physicians Guidelines recommends the antithrombotic therapy with Aspirin (50–100 mg/day) [34]. These Guidelines also state that the Warfarin therapy (target international normalized ratio, 2.5; range, 2–3) may be considered under certain circumstances for long-term stroke prevention [35]. Papillary fibroelastoma, the alternate diagnosis in our case, has a high risk of embolization, and surgical treatment is usually recommended [36]. This is the reason why surgical management was preferred in our case.

⧉ Conclusions

The caseous calcification of the mitral valve may also be encountered in younger patients lacking an association of multiple significant risk factors. It may sometimes have a less typical appearance, which makes it difficult to differentiate it from tumoral masses. Publishing these less typical cases is worthwhile in order to improve the entity’s diagnosis.

Conflict of interests

The authors declare that they have no conflict of interests regarding the publication of this paper.
  36 in total

1.  Caseous calcification of the mitral annulus.

Authors:  Harvinder Arora; Pankaj Madan; Leo Simpson; Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2008

2.  Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients.

Authors:  Dumbor L Ngaage; Charles J Mullany; Richard C Daly; Joseph A Dearani; William D Edwards; Henry D Tazelaar; Christopher G A McGregor; Thomas A Orszulak; Francisco J Puga; Hartzell V Schaff; Thoralf M Sundt; Kenton J Zehr
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

Review 3.  MRI assessment of cardiac tumours: part 1, multiparametric imaging protocols and spectrum of appearances of histologically benign lesions.

Authors:  Edward T D Hoey; Muhammad Shahid; Arul Ganeshan; Shobhit Baijal; Helen Simpson; Richard W Watkin
Journal:  Quant Imaging Med Surg       Date:  2014-12

4.  Big MAC: caseous calcification of the mitral annulus referred for possible cardiac tumor.

Authors:  Mangeet Chahal; Peter Temesy-Armos; William J Stewart
Journal:  Echocardiography       Date:  2011-03-10       Impact factor: 1.724

5.  Calcification of the mitral valve and annulus: systematic evaluation of effects on valve anatomy and function.

Authors:  Rajesh Movva; Kinnari Murthy; Abel Romero-Corral; Harish Raj Seetha Rammohan; Peter Fumo; Gregg S Pressman
Journal:  J Am Soc Echocardiogr       Date:  2013-07-19       Impact factor: 5.251

6.  Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study.

Authors:  Caroline S Fox; Ramachandran S Vasan; Helen Parise; Daniel Levy; Christopher J O'Donnell; Ralph B D'Agostino; Emelia J Benjamin
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

7.  Extensive calcification of the mitral valve anulus: pathology and surgical management.

Authors:  A F Carpentier; M Pellerin; J F Fuzellier; J Y Relland
Journal:  J Thorac Cardiovasc Surg       Date:  1996-04       Impact factor: 5.209

8.  Caseous Necrosis of Mitral Annulus.

Authors:  Sinan Balci; Selcuk Akkaya; Selin Ardali; Tuncay Hazirolan
Journal:  Case Rep Radiol       Date:  2015-08-18

9.  Multimodality imaging assessment of a caseous calcification of the mitral valve annulus.

Authors:  Imen Hamdi; Chadia Chourabi; Younes Arous; Mehdi Ghommidh; Khalil Houissa; Abdeddayem Haggui; Nadhem Hajlaoui; Dhaker Lahidheb; Nejmeddine Ben Abdallah; Wafa Fehri; Habib Haouala
Journal:  J Saudi Heart Assoc       Date:  2017-05-04

10.  Approach to An Unusual Cardiac Mass: Mitral Annulus Caseoma.

Authors:  Arda Aybars Pala; Hasan Iner; Murat Abdulhamit Ercisli
Journal:  Braz J Cardiovasc Surg       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.